Both the LEADER (liraglutide) and SUSTAIN-6 (subcutaneous semaglutide) trials reported significant reductions in the primary outcome (incidence of MACE)
Herbamama's chewable energy supplement is pectin-based for a smooth easy-to-chew texture
Serious and rarer side effects can include muscle cramping, irregular heartbeat, shortness of breath, slurred speech, vision changes, chest pain and weakness on one side of the body
BPC-157, a stable 15-amino-acid pentadecapeptide derived from a fragment of human gastric juice protein BPC, has been characterised in published research for its effects on angiogenesis, growth-factor signalling and connective-tissue repair across a wide range of injury models
Variability in study design, sample size, and supplement formulations leads to inconsistent results